These findings are in agreement with a study of colon cancer in which actinomycin-D treatment blocked CYP24A1 splicing, while cycloheximide did not affect calcitriol-induced CYP24A1 splicing [44]. The gene discussed is CYP24A1; the disease is malignant colon neoplasm.